Saving the Lives of People with Blood Cancer
by
At Anthony Nolan, we recently moved away from using the ‘100-day milestone’ that’s often talked about in relation to a stem cell transplant, in part because patients told us they don’t want a timeline attached to their recovery. Patients like George Norton, who received a transplant and went on to be a patient representative on…
by
Our Lead Nurse, Hayley Leonard, talks about how we’re changing our approach to patient information to move away from timelines, and focus on patient experience. Timelines are often used in medicine as a marker for recovery. For stem cell transplant patients, we’ve seen this in the emphasis on 100 days and one year after transplant….
by
In this blog, our Patient Information Writer and Researcher, Jonathan Kay, takes a closer look at the latest developments in and potential benefits of allo CAR T-cell therapy. Chimeric Antigen Receptor (CAR) T-cell therapy is an exciting new treatment that has recently been approved for children with B-cell acute lymphoblastic leukaemia (ALL), and adults with…
by
It is September 2015 and my wife, Claire, and I are on holiday in Orlando, Florida. It’s one of our favourite places. We’d just moved back to the UK after four years of hard work in Australia. The move turned out to be fortunate timing, because of what we were about to go through. When…
by
Naa Yeye was only 18 when she was diagnosed with blood cancer. 15 years later, she’s still dealing with long-term side effects, while also looking to share her story to help people from black, Asian and minority ethnic backgrounds not feel alone while going through cancer and a stem cell transplant. She spoke to Caroline…
by
Jessica Fuidge is an Anthony Nolan post-transplant paediatric Clinical Nurse Specialist (CNS), working at Bristol Royal Hospital for Children. She spoke to Caroline in Patient Services about her job supporting children going through a stem cell transplant and their families. Can you tell me a bit about your career and how you came to…
